Literature DB >> 1425349

Developmental expression of the Xenopus int-2 (FGF-3) gene: activation by mesodermal and neural induction.

D Tannahill1, H V Isaacs, M J Close, G Peters, J M Slack.   

Abstract

We have used a probe specific for the Xenopus homologue of the mammalian proto-oncogene int-2 (FGF-3) to examine the temporal and spatial expression pattern of the gene during Xenopus development. int-2 is expressed from just before the onset of gastrulation through to prelarval stages. In the early gastrula, it is expressed around the blastopore lip. This is maintained in the posterior third of the prospective mesoderm and neuroectoderm in the neurula. A second expression domain in the anterior third of the neuroectoderm alone appears in the late gastrula, which later resolves into the optic vesicles, hypothalamus and midbrain-hindbrain junction region. Further domains of expression arise in tailbud to prelarval embryos, including the stomodeal mesenchyme, the endoderm of the pharyngeal pouches and the cranial ganglia flanking the otocyst. It is shown, by treatment of blastula ectoderm with bFGF and activin, that int-2 can be expressed in response to mesoderm induction. By heterotypic grafting of gastrula ectoderm into axolotl neural plate, we have also demonstrated that int-2 can be expressed in response to neural induction. These results suggest that int-2 has multiple functions in development, including an early role in patterning of the anteroposterior body axis and a later role in the development of the tail, brain-derived structures and other epithelia.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425349     DOI: 10.1242/dev.115.3.695

Source DB:  PubMed          Journal:  Development        ISSN: 0950-1991            Impact factor:   6.868


  15 in total

Review 1.  Origin of the vertebrate inner ear: evolution and induction of the otic placode.

Authors:  A Streit
Journal:  J Anat       Date:  2001 Jul-Aug       Impact factor: 2.610

2.  A role for maternal beta-catenin in early mesoderm induction in Xenopus.

Authors:  Anne Schohl; François Fagotto
Journal:  EMBO J       Date:  2003-07-01       Impact factor: 11.598

3.  Expression of Fgf-3 in relation to hindbrain segmentation, otic pit position and pharyngeal arch morphology in normal and retinoic acid-exposed mouse embryos.

Authors:  R Mahmood; I J Mason; G M Morriss-Kay
Journal:  Anat Embryol (Berl)       Date:  1996-07

4.  Wnt antagonism initiates cardiogenesis in Xenopus laevis.

Authors:  V A Schneider; M Mercola
Journal:  Genes Dev       Date:  2001-02-01       Impact factor: 11.361

5.  FGF-dependent midline-derived progenitor cells in hypothalamic infundibular development.

Authors:  Caroline Alayne Pearson; Kyoji Ohyama; Liz Manning; Soheil Aghamohammadzadeh; Helen Sang; Marysia Placzek
Journal:  Development       Date:  2011-06       Impact factor: 6.868

6.  Fibroblast growth factor receptor-mediated rescue of x-ephrin B1-induced cell dissociation in Xenopus embryos.

Authors:  L D Chong; E K Park; E Latimer; R Friesel; I O Daar
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

7.  FGF8 initiates inner ear induction in chick and mouse.

Authors:  Raj K Ladher; Tracy J Wright; Anne M Moon; Suzanne L Mansour; Gary C Schoenwolf
Journal:  Genes Dev       Date:  2005-03-01       Impact factor: 11.361

8.  The ETS transcription factor Etv1 mediates FGF signaling to initiate proneural gene expression during Xenopus laevis retinal development.

Authors:  Minde Willardsen; David A Hutcheson; Kathryn B Moore; Monica L Vetter
Journal:  Mech Dev       Date:  2013-11-09       Impact factor: 1.882

9.  A role for Syndecan-4 in neural induction involving ERK- and PKC-dependent pathways.

Authors:  Sei Kuriyama; Roberto Mayor
Journal:  Development       Date:  2009-01-14       Impact factor: 6.868

10.  Lrig3 regulates neural crest formation in Xenopus by modulating Fgf and Wnt signaling pathways.

Authors:  Hui Zhao; Kosuke Tanegashima; Hyunju Ro; Igor B Dawid
Journal:  Development       Date:  2008-02-20       Impact factor: 6.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.